Could the 2010 HIV outbreak in Athens, Greece have been prevented? A mathematical modeling study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
10
05
2021
accepted:
22
09
2021
entrez:
7
10
2021
pubmed:
8
10
2021
medline:
24
11
2021
Statut:
epublish
Résumé
In 2009 and 2010, Athens, Greece experienced a hepatitis C virus (HCV) and a Human Immunodeficiency Virus (HIV) outbreak among People Who Inject Drugs (PWID), respectively. The HCV outbreak was not detected, while that of HIV was identified in 2011. The integrated HIV-interventions, launched in early 2012, managed to reduce directly the HIV incidence and indirectly the HCV incidence. This study aims to assess what would have been the course of the HIV outbreak and its associated economic consequences if the 2009 HCV outbreak had been detected and integrated interventions had been initiated 1- or 2-years earlier. The model was calibrated to reproduce the observed HIV epidemiological and clinical parameters among PWID of Athens, Greece. We examined the effect of the 1- or 2-years earlier detection scenarios, the 1-year later detection, the non-detection scenario, and compared them to the status quo scenario. Cumulative HIV cases, under the status-quo scenario during 2009-2019, were 1360 (90% Credible intervals: 290, 2470). If the HCV outbreak had been detected 1- or 2- years earlier, with immediate initiation of integrated interventions, 740 and 1110 HIV cases could be averted by 2019, respectively. Regarding the costs, if there was an efficient notification system to detect the HCV outbreak 1 or 2 years earlier, 35.2-53.2 million euros could be saved compared to the status quo by 2019. If the HCV outbreak had been detected and promptly addressed, the HIV outbreak would have been prevented and 35.2-53.2 million euros could have been saved.
Identifiants
pubmed: 34618836
doi: 10.1371/journal.pone.0258267
pii: PONE-D-21-15428
pmc: PMC8496824
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0258267Déclaration de conflit d'intérêts
IG, KS, NG, AF: No conflicts of interest. GT: Grants unrelated to this study and paid to her institution from Gilead Sciences Europe, UCL, ECDC, EU, University of Bristol, Harvard University, and National funds.
Références
Clin Infect Dis. 2020 Mar 3;70(6):1096-1102
pubmed: 31143944
PLoS One. 2015 Apr 15;10(4):e0122367
pubmed: 25875598
BMJ. 2010 Oct 26;341:c5475
pubmed: 20978062
Lancet Public Health. 2018 Sep;3(9):e429-e437
pubmed: 30122559
Addiction. 2010 Feb;105(2):311-8
pubmed: 19922515
Sex Transm Dis. 2006 Feb;33(2):111-7
pubmed: 16432483
AIDS. 2002 Mar 8;16(4):597-603
pubmed: 11873003
J Viral Hepat. 2019 Nov;26(11):1311-1317
pubmed: 31322302
Subst Use Misuse. 2015;50(7):885-90
pubmed: 25723311
HIV Med. 2008 May;9(5):261-9
pubmed: 18400074
Drug Alcohol Depend. 2008 Aug 1;96(3):281-5
pubmed: 18434044
J Int AIDS Soc. 2020 Jun;23 Suppl 1:e25493
pubmed: 32562375
AIDS. 2015 Aug 24;29(13):1701-10
pubmed: 26372281
Subst Use Misuse. 2015;50(7):825-38
pubmed: 25723309
BMC Public Health. 2016 Dec 3;16(1):1216
pubmed: 27912737
Lancet. 2020 Mar 14;395(10227):854
pubmed: 32171396
Euro Surveill. 2011 Sep 08;16(36):
pubmed: 21924120
Addiction. 2015 Sep;110(9):1453-67
pubmed: 26032121
AIDS. 2017 May 15;31(8):1181-1190
pubmed: 28323752
J Infect Dis. 2017 May 15;215(10):1496-1505
pubmed: 28407106
Curr HIV Res. 2017;15(6):396-404
pubmed: 29165088
Addiction. 2017 Jul;112(7):1290-1299
pubmed: 28107585
Glob Public Health. 2021 Aug-Sep;16(8-9):1167-1186
pubmed: 33843462
PLoS One. 2013 Nov 12;8(11):e78941
pubmed: 24265730
J Viral Hepat. 2008 Nov;15(11):809-16
pubmed: 18761605
Epidemics. 2010 Sep;2(3):155-164
pubmed: 21352786
Value Health Reg Issues. 2014 Sep;4:82-86
pubmed: 29702812
Am J Epidemiol. 2008 Nov 15;168(10):1099-109
pubmed: 18849303
Lancet HIV. 2018 Oct;5(10):e578-e587
pubmed: 30033374
Int J Drug Policy. 2021 Feb;88:103032
pubmed: 33212371
Lancet Infect Dis. 2009 Feb;9(2):118-29
pubmed: 19179227
Lancet HIV. 2018 Oct;5(10):e569-e577
pubmed: 30220531
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):323-331
pubmed: 27763996
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207
pubmed: 29074409
J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):414-20
pubmed: 22481603
AIDS Res Hum Retroviruses. 2021 Feb;37(2):130-138
pubmed: 33126818